MiR-21 Expression in Wilms’ Tumor

Document Type: Original Research

Authors

1 Tehran university of medical sciences, Tehran, Iran

2 Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran, Department of Experimental Therapeutics, MD Anderson Cancer Center, University of Texas, Houston, Texas,

3 Fellow of molecular pathology and cytogenetic, Tehran University Medical Sciences, Tehran, Iran. Associate professor of pathology, Iran University Medical Sciences, Tehran, Iran

4 Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University,Tehran, Iran

5 Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

6 Cell Based Therapies Research Center , Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background and Objective: Wilms’ tumor (WT) is the most common genitourinary tract tumor in children. MicroRNAs (miRNAs) are small non-coding RNAs; their role in the pathogenesis of many types of human cancers has been identified. We aimed to evaluate the expression of miR-21, a well-known oncomir, in WT tissue samples which is a very common urinary tract malignancy in children.
Methods: We performed chromogenic in situ hybridization (CISH) to detect the sub-cellular localization of miR-21 in 25 formalin-fixed, paraffin-embedded (FFPE) samples of WT. We also evaluated miR-21 expression in 24 of these blocks and 6 normal kidneys as controls using quantitative real-time PCR technique.
Results: While our real-time PCR analysis showed miR-21 significant overexpression in 4 tumors compared to the normal kidney samples, we could not detect significant ISH signal in any of these samples.
Conclusion: Low expression of miR-21 in WT might pinpoint the weak involvement of this miRNA in the pathogenesis of this cancer.

Keywords

Main Subjects